STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy
Author:
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
http://www.mdpi.com/2072-6694/6/4/1986/pdf
Reference160 articles.
1. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial;Rodel;Lancet Oncol.,2012
2. Progress and controversies: Radiation therapy for invasive breast cancer;Jagsi;CA Cancer J. Clin.,2013
3. Management of non-small-cell lung cancer: Recent developments;Reck;Lancet,2013
4. Past, present, and future of radiotherapy for the benefit of patients;Thariat;Nat. Rev. Clin. Oncol.,2013
5. The concurrent chemoradiation paradigm—General principles;Seiwert;Nat. Clin. Pract. Oncol.,2007
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma;Translational Oncology;2024-08
2. Interleukin-6 serves as a critical factor in various cancer progression and therapy;Medical Oncology;2024-06-20
3. PLAU promotes cell proliferation and migration of head and neck cancer via STAT3 signaling pathway;Experimental Cell Research;2024-05
4. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04
5. Revisiting the role of endogenous STAT3 in HPV‐positive cervical cancer cells;Journal of Medical Virology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3